[Temodal--an alkylating cytostatic agent. Effectiveness in patients with malignant gliomas].
M V
MV
Matsko
D000284:Administration, Oral; D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002166:Camptothecin / Q000008:administration & dosage / Q000031:analogs & derivatives; D016543:Central Nervous System Neoplasms / Q000188:drug therapy; D017024:Chemotherapy, Adjuvant; D003606:Dacarbazine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004317:Doxorubicin / Q000008:administration & dosage; D004334:Drug Administration Schedule; D005910:Glioma / Q000188:drug therapy*; D006801:Humans; D000077146:Irinotecan; D000077204:Temozolomide
D018906:Antineoplastic Agents, Alkylating; D000077146:Irinotecan; D003606:Dacarbazine; D004317:Doxorubicin; D002166:Camptothecin; D000077204:Temozolomide